Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation

Sponsor
Schön Klinik Berchtesgadener Land (Other)
Overall Status
Terminated
CT.gov ID
NCT03477526
Collaborator
Lungenfibrose e.V. (Other)
1
1
2
1
30.4

Study Details

Study Description

Brief Summary

As the result of our last study "Long Term effects of an Inpatient Pulmonary Program in Patients with Pulmonary Fibrosis" already demonstrated the positive effects of a Pulmonary Rehabiliation on the mental status. In this current study the aim will be to analyse the personality type regarding anxiety and depression

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pulmonary rehabilitation program
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
1 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Status and Develepment Mental Quality of Life in Lung Fibrosis in Comparison of COPD Inpatients Before and After Pulmonary Rehabilitation
Actual Study Start Date :
Feb 26, 2019
Actual Primary Completion Date :
Feb 27, 2019
Actual Study Completion Date :
Feb 27, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: COPD patients (GOLD stage III-IV)

Procedure: Pulmonary rehabilitation program
3 weeks, ...

Active Comparator: IPF patients

Procedure: Pulmonary rehabilitation program
3 weeks, ...

Outcome Measures

Primary Outcome Measures

  1. Anxiety score [3 weeks]

    Hospital Anxiety and Depression scale

Secondary Outcome Measures

  1. Anxiety score [3 months]

    Hospital Anxiety and Depression scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • COPD GOLD III-IV

  • IPF according Pulmonary Guidelines

Exclusion Criteria:

< 30% FVC comorbidities with a negativ influence on the prognosis neurological and orthopaedic deficits, which make the participation of the pulmonary rehabilitation impossible non-compliance no written informed consent of the patient

Contacts and Locations

Locations

Site City State Country Postal Code
1 Schön Klinik Berchtesgadener Land Schönau a.Königssee Germany 83471

Sponsors and Collaborators

  • Schön Klinik Berchtesgadener Land
  • Lungenfibrose e.V.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Klaus Kenn, Principal Investigator, Schön Klinik Berchtesgadener Land
ClinicalTrials.gov Identifier:
NCT03477526
Other Study ID Numbers:
  • Fibrosis 2016
First Posted:
Mar 26, 2018
Last Update Posted:
Nov 13, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Klaus Kenn, Principal Investigator, Schön Klinik Berchtesgadener Land
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 13, 2020